Merck has announced a significant workforce reduction, letting go of approximately 6,000 employees, which constitutes about 8% of its global workfo...
Moderna is reducing its global workforce by 10%, bringing its headcount to under 5,000 employees. CEO Stéphane Bancel announced the decision as par...
Bristol Myers Squibb has reported its financial results for the second quarter of 2025. The company, headquartered in Princeton, New Jersey, is hos...
Bristol Myers Squibb has released its financial results for the second quarter of 2025. The announcement was made from Princeton, New Jersey, and d...
Johnson & Johnson, founded in 1886 in New Brunswick, N.J., has become a leader in pharmaceuticals, medical devices, diagnostics, and consumer healt...
Bristol Myers Squibb (BMS) has announced an expansion of its cost-cutting measures, adding $2 billion in savings through 2027. This move is part of...
Sandoz has signed a non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics development and manufacturing capabilities in Toulou...
The global market for infectious disease treatments is expected to grow significantly, from $72.5 billion in 2025 to $101 billion by 2030, with a c...
Bristol Myers Squibb (BMS) has partnered with Bain Capital to launch a new biotech company focused on developing therapies for autoimmune disorders...
Merck has reported a decline in its quarterly sales and net income, alongside a narrowed sales guidance for 2025. Despite these financial setbacks,...